Performance of Quantitative Buffy Coat, QBC Fluorescence and Staining Technologies™ Test, and SD Bioline™ Malaria Rapid Test in Malaria Diagnosis in Western Kenya by Adera, Anastasia et al.
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 
ISSN 2422-8419     An International Peer-reviewed Journal 
Vol.40, 2017 
 
38 
Performance of Quantitative Buffy Coat, QBC Fluorescence and 
Staining Technologies™ Test, and SD Bioline™ Malaria Rapid 
Test in Malaria Diagnosis in Western Kenya 
 
Anastasia Adera1*      Peter Obare2, 3      Andrew Nyerere1      Hellen Kutima1      Angela Achieng3 
Hoseah Akala3      John Ong’echa4      Bernhards Ogutu2, 3 
1.School of Biological Sciences, Jomo Kenyatta University of Agriculture and Technology, PO box 62000-
00200, Nairobi, Kenya 
2.Malaria Diagnostics Centre, Centre for Clinical Research, Kenya Medical Research Institute, PO box 54-
40100, Kisumu, Kenya 
3.Department of Emerging Infectious Disease, United States Army Medical Research Unit-Kenya (USAMRU-
K), Kenya Medical Research Institute (KEMRI)/Walter Reed Project, PO box 54-40100, Kisumu, Kenya 
4.Centre for Global Health Research, Kenya Medical Research Institute, PO box 1578-40100, Kisumu Kenya 
 
Abstract 
Malaria remains the most important parasitic disease in sub-Saharan Africa as a cause of morbidity and 
mortality.  Effective management of malaria relies on prompt and accurate diagnosis to guide treatment.  The 
World Health Organization (WHO) recommends that all suspected malaria cases be tested before initiation of 
treatment, thus diagnosis of malaria requires parasitological confirmation of malaria parasites in the blood of 
suspected patients.  This cross-sectional study conducted at the Ahero County Hospital, Kisumu, Kenya, 
evaluated the performance of quantitative buffy coat (QBC) (QBC Fluorescence and Staining 
Technologies™(QBC F.A.S.T.™)-improved QBC system and SD Bioline™ malaria rapid tests) against 'gold 
standard' (Giemsa blood stained slides microscopy) for the detection of Plasmodium species in children<five 
years old (n=385)in a malaria holo-endemic area of western Kenya.  Real-time PCR was performed on 
discrepant samples across the tests and the gold standard (microscopy).Sensitivity of QBC, QBC F.A.S.T.™ and 
SD Bioline™ malaria rapid tests were 90% (95% CI: 85-94), 77% (95% CI: 71-83) and 91% (95% CI: 86-94), 
respectively, while specificity was 30% (95% CI: 24-37), 83% (95% CI: 77-88) and 67% (95% CI: 60-73), 
respectively.  The positive predictive values (PPV) were 58% (95% CI: 52-63), 83% (95% CI: 77-88) and 74% 
(95% CI: 63-80), respectively, while the negative predictive values (NPV) were 74% (95% CI: 63-84), 78% 
(95% CI: 71-83) and 87% (95% CI: 81-92), respectively.Although the standard QBC malaria test and the SD 
Bioline™ malaria rapid diagnostic test (RDT) showed better sensitivity relative to the improved QBC F.A.S.T.™ 
test, the latter had a better specificity.  The performance of these tests remains modest against microscopy. 
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1. Introduction  
People living in more than 97 countries around the world remain at risk of malaria, with 198 million cases and 
about584,000 of deaths reported in 2013 (WHO 2014).  Over 80% of these deaths occur in sub-Saharan Africa 
(WHO 2011).  Malaria diagnosis and prompt treatment with artemisinin combination therapy (ACT) remains the 
mainstay of malaria control in Africa (Gosling 2008).  Parasitological diagnosis is the diagnostic cornerstone of 
choice since malaria symptoms and signs overlap with other febrile diseases (White 2005).  The World Health 
Organization (WHO)currently recommends that all suspected malaria cases be parasitologically-confirmed 
before initiating treatment (WHO 2010) and this has been adopted by many countries, including Kenya.  By 
2013, the WHO African Region reported the largest increase in the number of suspected cases being tested 
(62%) compared to 47% in 2010 when this was initiated (WHO 2014). 
Confirmatory malaria infection requires the availability of affordable, rapid, sensitive, and specific tests. 
Currently, the malaria diagnosis 'gold standard' method remains light microscopy with a variable limit of 
detection of 20-40 parasites/µL in good hands (Schindler et al. 2001).  Microscopy also allows estimation of 
parasite density.  However, the technique is human dependant, labour intensive requiring well-trained 
microscopists for reliable accurate results.  Microscopy is not readily deployable in remote areas that lack 
equipped laboratories (Pinto et al. 2001).  Due to these limitations there has been an increase in development of 
alternative diagnostic tools.  A number tools, such as quantitative buffy coat (standard QBC) test and 
immunochromatographic tests such as rapid diagnostic tests (RDTs) have been developed and deployed for 
routine to complement microscopy.  These methods have been found to be easier to use, sensitive and accurate 
(Bhandari et al. 2008)(RDT evaluation programme) but these methods detect malaria antigens in blood.  Most 
RDTs available on the market target Plasmodium falciparum-specific,histidine-rich protein II (HRP-2) and 
Plasmodiumlactate dehydrogenase enzyme (p-LDH).  Some tests detect pan-specific pLDH or adolase from the 
parasite glycolytic pathway found in all Plasmodium species (Wongsrichanalai et al. 2007).  A well-known 
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limitation of the RDT is the occurrence of false positive results caused by persistent antigenaemia even after 
effective anti-malarial treatment.  This is peculiar to those tests that detect the parasite antigen HRP-2 specific to 
P.falciparum (Gitonga W. Caroline and Snow W. Robert 2012).  More sensitive molecular techniques, such as 
polymerase chain reaction (PCR) and flow cytometry, have also been explored in laboratories to enhance 
detection of malaria parasites at very low parasite densities.  These molecular methods remain costly, limiting 
their use to reference laboratories (Tangpukdee et al. 2009).  All these techniques have their own limitations with 
respect to sensitivity, specificity, turnaround time, cost effectiveness, and ease of performance of procedures. 
Even though there has been a rapid increase the use of RDTs globally, like other biological tests, malaria 
RDTs are temperature sensitive (Gitonga W C and Snow W R 2012) and performance alters in case of exposure 
to extremes of weather.  There is a need to develop and deploy more robust methods.  This study evaluated the 
performance of the QBC malaria test, QBC F.A.S.T.™test (improved QBC)and the SD Bioline™ malaria RDT 
against microscopy using Giemsa-stained blood slides for malaria diagnosis in young children aged <five years 
residing in a malaria holo-endemic area of western Kenya.      
 
2. Methods 
2.1 Study area 
The study was conducted from May to September, 2013 at the Ahero County Hospital in Kisumu County, 
Kenya.  The study area is situated in a rice irrigation scheme with high malaria transmission (Bukhari 2011).  
The hospital has antenatal and child health clinics from Mondays to Fridays from where potential study 
participants were screened and enrolled. 
 
2.2 Study design 
A hospital-based, cross-sectional study was conducted in children <five years of age at the Ahero County 
Hospital, Kisumu County, Kenya after fulfilling the inclusion criteria (children aged six-59 months presenting 
with fever and who had not taken any anti-malarial drugs within 14 days of reporting to the hospital,fever of 
≥37.5°C).  Individuals who had taken anti-malarial drugs within 14 days of reporting to the hospital were 
excluded from the study.  The children were enrolled after parents/guardians provided a written informed 
consent obtained by research nurses and clinicians.   
 
2.3 Ethical approval 
The study was approved by National/Kenya Medical Research Institute Ethics Review Committee, Kenya (SSC# 
2008). 
 
2.4 Sample collection  
Consecutive parents/guardians of patients aged six-59 months presenting at the study site were approached by 
study nurse/clinicians for recruitment.  After consenting, capillary blood samples by finger-prick were collected 
into 0.5 mL microtainers (K2EDTA-BD, USA) and processed within 2 hours of collection.  The sample 
processing and conduct of the malaria diagnosis tests were performed at the study site by trained laboratory 
technicians.  Prior to study initiation the technicians had a refresher training on malaria diagnosis methods by the 
Malaria Diagnostic Centre team, Centre Clinical Research, Kenya Medical Research Institute, Kisumu.  
2.4.1 Quantitative buffy coat test 
Approximately (55-65µL) of blood samples were filled into QBC capillary tubes by tilting the well-mixed blood 
tubes and placing the capillary tubes nearest to the blue lines in contact with the blood, keeping the tubes slightly 
above horizontal.  The tubes were then rolled several times so as to mix the blood with the white anticoagulant 
coating, then tilted to allow blood to flow to the opposite end of the tubes into the orange reagent coating to mix 
with the acridine orange coating.  The tubes were then sealed and a float inserted into each tube at the unsealed 
end and centrifuged at 12,000 rpm for 5 min.  The centrifuged QBC tubes were then inserted into a paraviewer, 
two to three drops of fluorescence optical oil added for examination of the buffy coat area at 1,000× 
magnification using ParaLens Advance LED fluorescence attachment.  The samples were processed and read at 
the study site by one of the study technicians. 
2.4.1.1 Preparation of thick and thin blood films 
Two thick and thin films per sample were prepared from each sample using6µL of blood to prepare thick film 
and 2µLfor thin film.  The slides were air-dried and thin films were then fixed in methanol before the slides were 
singly stained with QBC F.A.S.T.™ or 10% Giemsa (Obare et al. 2013). 
2.4.2 QBC F.A.S.T.™test 
Thick films were individually flooded with F.A.S.T. Malaria stain for 10 min followed by fresh water for 5 min.  
Thin films were flooded with the stain for 45 sec and then rinsed by dipping in fresh water five times singly.  
Films were allowed to air dry vertically before examination.  Examination of films was performed in a dark 
room with the aid of a ParaLens Advance LED fluorescence attachment at 1,000× magnification.  A slide was 
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only considered negative if no parasites were detected after 100 fields were examined.  Parasites were viewed as 
small fluorescent bodies with typical malaria morphological shapes. 
2.4.3 Giemsa microscopy  
Buffered water was used to prepare a 10% working Giemsa solution before staining.  Blood films were 
individually flooded with the stain for 15 min followed by rinsing with water.  Films were allowed to air dry 
vertically before examination.  Examination of the films was performed with the aid of a light microscope at 
1,000× magnification.  A slide was considered negative if no parasites were detected on examining 100 
microscopic fields. 
All slides were read independently by two study technicians and a third reader (tie breaker) in case of 
discrepancy at the Malaria Diagnostic Centre, Centre Clinical Research, Kenya Medical Research Institute, 
Kisumu. 
2.4.4 Quantification of parasite densities by QBC F.A.S.T.™ and Giemsa methods 
Thick blood films were examined against 200 leukocytes.  Parasite densities were estimated as parasites per 
volume assuming 8,000 leukocytes/µL of blood.  If the parasites counted per microscopic field were 100 or 
more, then thin blood film examination was recorded by counting the number of parasitized cells against 2,000 
red blood cells (RBCs) and converted to number of parasites per volume assuming 450,000 RBCs/µL of blood.  
 
2.5 SD Bioline™malaria rapid test 
Blood samples were added to the round wells followed by four drops of assay diluents into the square assay well.  
Results were read after 15 min.  A negative result was indicated with the presence of one colour band, a positive 
result with two colour bands and an invalid result if the control line failed to appear and the test repeated with a 
new device. 
A negative result by QBC, QBC F.A.S.T.™, SD Bioline™, and Giemsa microscopy was considered as true-
negative because the risk for false positive microscopy results was considered low since the slides were all read 
independently by two experienced technicians and a third tie breaker. 
 
2.6 Malaria parasite identification by PCR 
Giemsa-stained blood films were soaked with 10 μL of phosphate buffered saline (PBS) 0.02 M, pH 7.4) then 
scraped off the glass slide by making circular movements with a sterile scalpel (Farla Medicals, Antwerp, 
Belgium).  For each blood film, a separate scalpel was used.  The collected material was transferred in a sterile 
1.5-mL tube which contained 90 μL PBS.  DNA was extracted with the QIAamp DNA Blood mini kit (Qiagen 
Benelux, Venlo, TheNetherlands) according to manufacturer’s instructions.  The standard used in the assay was 
the WHO International Standard for P. falciparum DNA Nucleic Acid Tests (NAT) obtained from National 
Institute for Biological Standards and Control (NIBSC; Hertfordshire, UK) as described by  (Kamau et al. 2013). 
2.6.1 Real-time PCR on blood films 
Primers and probes for the amplification of the Plasmodium species were used to target PLU3 gene of all 
Plasmodium species and RNAse P, a human housekeeping gene, as described previously (Kamau et al. 2013).  
The assay was performed with the Applied Biosystems 7500 Fast Real-time PCR System, v.2.0.5 software.  The 
thermal profile used for the qPCR was as follows: 5 min at 96°C, 40 cycles of 10secat 96°C; 30 sec at 60°C, 
with fluorescence collected at 60°C step.  Each reaction contained 1 μL of template DNA and a reaction master 
mix containing Quantifast Probe Master Mix with Rox dye (QIAGEN,USA),10μMof each primer,5 μM of each 
probe, and dH2O.  All assays were run with the appropriate controls including non-template control. 
Real-time PCR was performed on 40% of the discrepant results at the Malaria Drug Resistance 
Laboratories, Kenya Medical Research Institute, Kisumu Kenya.  All laboratory personnel were blinded to the 
results from each of the tests. 
 
2.7 Data Analysis 
Data analysis was conducted using SPSS software package Version 20.0 (IBM SPSS Inc, Chicago, IL, USA) and 
GraphPadSoftware, Version 5 (GraphPad Software, Inc, La Jolla, CA, USA).  The performance of the tests 
(QBC, QBC F.A.S.T.™ and SD Bioline™) against Giemsa microscopy was expressed as true-positive (TP), 
true-negative (TN), false-positive (FP), or false-negative (FN).  The formulae used to calculate performance 
were TP/TP+FN for sensitivity (SS), TN/TN+FP for specificity (SP), TP/TP+FP for positive predictive values 
(PPV) and TN/TN+FN for negative predictive values(NPV).  The results were interpreted with 95% confidence 
intervals (CI95).  Agreement between tests was determined by calculating Kappa statistics with 95% CIs and 
interpreted with the Landis and Koch classification.  Relationship in parasite densities between Giemsa 
microscopy slide reads and QBC F.A.S.T.™ slide reads was determined using Pearson’s correlation co-efficient. 
P values <0.05 were considered statistically significant. 
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3. Results  
3.1 Performances of the tests 
A total of 385 samples were tested.  The total number of positive cases was found to be high with QBC test 
(310/385) as compared to the other tests (Table 1).  Overal, SD Bioline™ had the highest sensitivity (91%) with 
QBC F.A.S.T.™ demonstrating a lower sensitivity (67%) when compared to the other tests.  On the other hand, 
QBC test reported the lowest specificity of 30% as compared to 83% and 67% of QBC F.A.S.T.™ and SD 
Bioline™ tests respectively(Table 2).  A total of 32 samples were found to be negative by both QBC, QBC 
F.A.S.T.™, SD Bioline™, and Giemsa microscopy. 
Table 1. The total number of positives and negatives for each test in the study 
Tests Positive (%) Negative (%) Total 
QBC 310 (81%) 75 (19%) 385 
QBC F.A.S.T.™ 185 (48%) 200 (52%) 385 
SD Bioline™ 242 (63%) 143 (37%) 385 
Giemsa  198 (51%) 187 (49%) 385 
QBC test gave the highest number of positive cases 310 (81%) while QBC F.A.S.T.™ 185 (48%) test gave the 
lowest number of positive cases as compared to the other tests. 
Table 2. Diagnostic Performance of QBC, QBC F.A.S.T.TM and SD Bioline TM using Giemsa as the gold 
standard and pair-wise comparison of concordant tests. 
Tests Sensitivity Specificity Positive Predictive 
Value(PPV) 
Negative 
Predictive 
Value(NPV) 
Kappa (95%CI) 
QBC 90 
(85-94) 
30 
(24-37) 
58 
(52-63) 
74 
(63-84) 
0.45 
(0.38- 0.52) 
QBC 
F.A.S.T.TM 
77 
(71-83) 
83 
(77-88) 
74 
(63-80) 
78 
(71-83) 
0.61 
(0.53-0.69) 
SD 
BiolineTM 
91 
(86-94) 
67 
(60-73) 
83 
(77-88)  
87 
(81-92) 
0.58 
(0.50-0.663) 
SD BiolineTM had the highest sensitivity 91% followed by QBC and lastly QBC F.A.S.T.TM while QBC had the 
lowest specificity 30% as compared to the other tests 
Three-hundred and eighty-five samples were tested by all the four tests, of which QBC and Giemsa 
microscopy had the highest number of discrepant results.  One-hundred and thirty-one samples were found 
positive by QBC and not by Giemsa, hence 40% (n=52) of the discrepant results were randomly picked and 
further analysed by qPCR (Kamau et al. 2013) to ascertain the presence of Plasmodium DNA.  Out of the 52 
samples found to be malaria positive by QBC, only six samples (12%) had Plasmodium DNA by qPCR.   
Assessment of agreement between tests using Giemsa as the gold standard showed a moderate agreement 
with QBC test (k=0.45) and SD Bioline™ (k=0.58) and a substantial agreement with QBC F.A.S.T.™ (k=0.61) 
(Table 2).  The other tests had a rather poor agreement when compared to each other: QBC vs QBC F.A.S.T.™ 
(k=0.29), QBC vs SD Bioline™ (k=0.14) and SD Bioline™ vs QBC F.A.S.T.™(k=0.46) as shown in Table 3.  
The concordant rates of the tests relative to Giemsa microscopy were 90.4% (170/198; QBC), 77.3% (153/198; 
QBC F.A.S.T.™) and 90.9% with SD Bioline™ test. 
Table 3. Levels of agreement for all the tests QBC, QBC F.A.S.T.TM and SD Bioline™ compared to each 
other 
Tests QBC VsQBC F.A.S.T. QBC VsSD Bioline SD Bioline VsQBC F.A.S.T. 
Kappa values 0.29(0.20-0.39) 0.14(0.04-0.23) 0.46(0.37-0.54) 
When the test agreement was compared against each they performed poorly with Kappa values of as low as 0.14. 
 
3.2 Assessment of parasite densities from QBC F.A.S.T.™test compared to Giemsa 
The continued implementation of different malaria control interventions aim at significantly reducing the 
morbidity and mortality associated with malaria, and possibly eliminate malaria.  The move towards elimination 
will require more sensitive tests to match the expected reduction in parasitaemia (The malERA Consultative 
Group 2011).  Consequently, we assessed the performance of the QBC F.A.S.T.™ test and Giemsa microscopy 
at different parasite densities (Fig.1).  There were 153positive cases by both QBC F.A.S.T.™test and Giemsa 
microscopy.  The positive cases were divided into three percentiles representing low parasitaemia (0th and 25th 
percentiles, n=37), moderate parasitaemia (26th to 75thpercentile, n=77), and high parasitaemia (76th to 100th 
percentile, n=39) so as to determine how the two tests compared at different parasite densities.  Overal, the two 
tests correlated relatively well when all the samples (n=153) were compared (r=0.645, P<0.0001; Fig.1A).  At 
low parasite densities (0th and 25th percentiles) this relationship was maintained, albeit at a weaker level 
(r=0.361, P=0.028; Fig.1B).  Similarly, at the moderate parasite density the two tests were significantly 
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correlated at a higher level than for the low parasitaemia (r=0.478, P<0.0001; Fig.1C).  In addition, at high 
parasite densities (76th to 100th percentile) this relationship was still maintained (r=0.470, P=0.003; Fig.1D).   
 
Fig.1Relationship of parasite densities between QBC F.A.S.T. ™ and Giemsa tests 
A) All positive samples (n=153); B) 0th to 25thpercentile (n=39); C) 26th to 75thpercentile (n=77); D) 76th to 
100thpercentile (n=37).  Analysis was performed using Pearson’s correlation coefficient. 
QBC F.A.S.T. ™ and Giemsa tests correlated relatively well (r=0.645, P<0.0001) on all positive cases (n=153) 
albeit they had a weaker correlation (r=0.361, P=0.028) at low parasitaemia (n=39).  
 
3.3 Species identification by QBC F.A.S.T™ test compared to Giemsa  
Of the 153 positive cases, QBC F.A.S.T.™ test detected 150 (98%)P.falciparum, zero (0%)Plasmodium ovale, 
zero (0%)Plasmodium malariae, and three(2%) mixed infections.  Giemsa microscopy detected 141 
(92.2%)P.falciparum, one(0.65%)P.malariae, one(0.65%)P.ovale, and ten (6.5%) mixed infections.  Despite the 
difference in identification of the mixed infections by both tests, the difference was comparable between the two. 
 
4. Discussion  
The QBC and the QBC F.A.S.T.™ tests are fluorescent-assisted microscopy (FAM)-based methods.  QBC had 
90% sensitivity, a finding that is consistent with previous studies (Schindler et al. 2001 Kuladeepa 2012 Sandhya 
2012).  The high sensitivity is possibly enhanced through concentration of parasitized erythrocytes and the large 
volume of blood collected for examination (Kuladeepa 2012).  However, the test showed a low specificity of 
30%, possibly due to high rates of false positives as confirmed by the qPCR results, whereas only 12% of the 
discrepant results had Plasmodium DNA.  The low specificity reported in this study is consistent with previous 
studies (Schindler et al. 2001, Morassin et al. 2002).  This could be explained by the presence of Howell-jolly 
bodies and artefacts (Bhandari et al. 2008 Sandhya 2012).  Concerns of leakage and breakage of blood-filled 
QBC tubes in the centrifuge are some of the pitfalls associated with this diagnostic approach as experienced in 
this study and by other studies (Pinto et al. 2001, Salmani 2011).  Despite the low specificity, QBC holds 
promise as a good alternative in malaria diagnosis due to its speed and sensitivity as reported by Datta and his 
team (Datta 2010). 
SD Bioline™ had the highest sensitivity compared to the other tests.  The high sensitivity of SD Bioline™ 
kits, which detect HRP-II antigen, gives confidence that most of the malaria cases in the study population were 
diagnosed in agreement with previous reports (Kosack et al. 2013).  Sensitivity improves with parasitaemia, 
however two cases with parasitaemia>10,000parasites/µL were diagnosed as negative.  The false negative results 
could possibly be explained by the pro-zone effect (Kosack et al. 2013).  A relatively low specificity of 67% 
obtained may have been due to the persistency of HRP-II antigen in the blood for up to 56 days after treatment 
(Nyunt et al. 2013), or the ability of the RDT to detect low parasite densities (Bell, 2002)or possible deletions of 
HRP-II (Gamboa et al. 2010), although this is rare in Africa (Baker and Kyle  DE, 2005).  These pose serious 
diagnostic challenge in malaria-endemic regions resulting in misdiagnosis with poor treatment outcome.  Despite 
A B 
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the test being unable to detect non-falciparum malaria, it targets the most lethal Plasmodium species  (Strom et 
al. 2013), hence greater impact.  QBC F.A.S.T.™ test was found to be easy to apply since it uses the same 
sample preparation procedure as Giemsa microscopy.  Positive cases were easily identified for parasitaemia 
levels >500 parasites/µL correlating to evaluation of a test that used the same fluorescence microscopy principle 
(Sousa-Figueiredo et al. 2010).  However, the test demonstrated low sensitivity when compared to the other tests 
and this could be due to lack of clearly defined ring stages of the parasites. 
The parasite densities in all positive cases by both Giemsa and QBC F.A.S.T.™ strongly correlated, 
indicating a good performance of QBC F.A.S.T.™ on quantitative diagnosis.  The weak correlation at low 
parasite densities could be attributed to the field of view by Giemsa microscopy, which is visually clear, 
enhancing distinct parasite morphology, making parasite counting easier compared to the challenges obtained 
from QBC F.A.S.T.™ test where the morphology of the parasite is not clearly visible. 
Accurate identification of Plasmodium species is critical because the results employed assist in correct 
deployment of specific control intervention strategies (Obare et al. 2013).  Prompt and correct case diagnosis 
leading to accurate epidemiological assessments and optimal case management remains a critical research 
agenda, especially in malaria-endemic areas (Sousa-Figueiredo et al. 2010).  Reliable differentiation of malaria 
infections is imperative since Plasmodium species differ in their biology, clinical symptoms and treatment 
regimens (Barber et al. 2013).  Importantly, QBC F.A.S.T.™ was found to differentiate between Plasmodium 
species making it applicable to regions where falciparum and non-falciparum malaria cases are common.  This 
was possible through the fluorescing of the parasites with typical malaria morphological stages.  The test 
however is not very satisfactory in the diagnoses of P. malariae due to the lack of a very clear visual distinction 
of the morphology of the parasite.  With the increased implementation of various control measures, significant 
reductions in malaria transmission intensities have been reported in some regions (O'Meara WP 2010).  The 
reduction in transmission intensities is expected to be accompanied by reduction in malaria parasite densities, 
which will require more sensitive diagnostics for better case management and possible elimination.  Despite 
malaria being a major cause of paediatric morbidity and mortality in most sub-Saharan African countries 
(Schumacher and Spinelli 2012), diagnostic tools development has remained slow and there is need for 
redoubled effort in the development of highly sensitive and robust point of care malaria diagnostics. 
Study limitations were performance of real-time PCR on only the discrepant results obtained between the 
tests, and the use of Giemsa blood-stained microscopy as the gold standard for the entire study samples 
compared to using real-time PCR which has a better parasite detection limit.  However, this was done because 
the risk of getting false positives was considered low as the slides were read by trained technicians and 
supervised by the Malaria Diagnostics Centre, Kisumu, Kenya.  Real-time PCR is a very useful gold standard in 
that it is highly sensitive, easily reproducible and can detect cases with low parasitaemia missed by other tests. 
Its limitation is that the test is very expensive and time- and labour-consuming, hence it is used only to confirm 
the accuracy of microscopy (Johnston et al. 2006). 
 
5. Conclusions  
QBC test still remains a sensitive, rapid and accurate optical test although it should be supplemented with 
Giemsa due to limitations in species determination and parasite quantification.  However, QBC is less sensitive 
compared to RDTs but the QBC F.A.S.T.™ test holds promise in rapid malaria diagnosis as differentiation of ring 
stage morphology is addressed. 
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